{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:25:41Z","timestamp":1791077141284,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":5839,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1093\/annonc\/mdh009","type":"journal-article","created":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T21:42:52Z","timestamp":1071870172000},"page":"146-150","source":"Crossref","is-referenced-by-count":142,"title":["Anthracyclines during pregnancy: embryo\u2013fetal outcome in 160 patients"],"prefix":"10.1016","volume":"15","author":[{"given":"N.","family":"Germann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goffinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh009_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00001703-200212000-00007","article-title":"Cancer and pregnancy: recent developments","volume":"14","author":"Ward","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1093\/annonc\/mdh009_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11864-000-0011-3","article-title":"Acute leukemia in adults","volume":"1","author":"Cripe","year":"2000","journal-title":"Curr Treat Options Oncol"},{"key":"10.1093\/annonc\/mdh009_bb0020","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.1997.15.3.1118","article-title":"Six cycles of ABVD in the treatment of stage I and II Hodgkin\u2019s lymphoma: a pilot study","volume":"15","author":"Rueda","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh009_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh009_bb0030","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1200\/JCO.1999.17.12.3706","article-title":"Results of treatment for soft tissues sarcoma in childhood and adolescence: a final report of the German Cooperative Soft tissue Sarcoma Study CWS-86","volume":"17","author":"Koscielniak","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh009_bb0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(02)00927-0","article-title":"Chemotherapy for metastatic breast cancer\u2014report of a European expert panel","volume":"3","author":"Crown","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdh009_bb0040","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1021\/bi00454a033","article-title":"Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA affinity and cytotoxicity","volume":"29","author":"Capranico","year":"1990","journal-title":"Biochemistry"},{"key":"10.1093\/annonc\/mdh009_bb0045","first-page":"2065","article-title":"Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by Adriamycin and Daunomycin","volume":"36","author":"Marquardt","year":"1976","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdh009_bb0050","series-title":"Topoisomerase II inhibitors: the epipodophyllotoxins, m-AMSA and the ellipticine derivate","first-page":"435","article-title":"Cancer Chemotherapy and Biotherapy","author":"Pommier","year":"1996"},{"key":"10.1093\/annonc\/mdh009_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/030089169207800513","article-title":"Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report","volume":"78","author":"Barni","year":"1992","journal-title":"Tumori"},{"key":"10.1093\/annonc\/mdh009_bb0060","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(79)92878-2","article-title":"Does doxorubicin cross the placenta?","volume":"2","author":"Roboz","year":"1979","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh009_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(83)91614-8","article-title":"Transplacental passage of doxorubicin","volume":"1","author":"D\u2019Incalci","year":"1983","journal-title":"Lancer"},{"key":"10.1093\/annonc\/mdh009_bb0070","first-page":"773","article-title":"Doxorubicin in pregnancy: possible transplacental passage","volume":"67","author":"Karp","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdh009_bb0075","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.1984.03350180061032","article-title":"Multimodal cancer therapy for breast cancer in the first trimester of pregnancy","volume":"252","author":"Murray","year":"1984","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdh009_bb0080","first-page":"488","article-title":"Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia\u2014neonatal and infantile course","volume":"153","author":"Artlich","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1093\/annonc\/mdh009_bb0085","first-page":"396","article-title":"A woman with a balanced autosomal translocation who received chemotherapy while pregnant","volume":"79","author":"Kim","year":"1996","journal-title":"Med Health RI"},{"key":"10.1093\/annonc\/mdh009_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2257.1989.tb00205.x","article-title":"Combination chemotherapy with conservative obstetric management in the treatment of pregnant patients with acute myeloblastic leukaemia","volume":"11","author":"Roy","year":"1989","journal-title":"Clin Lab Haematol"},{"key":"10.1093\/annonc\/mdh009_bb0095","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.1987.5.7.1098","article-title":"Acute leukemia during pregnancy: The Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents","volume":"5","author":"Reynoso","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh009_bb0100","first-page":"31","article-title":"Histological study of timing and embryology of notochordal abnormalities in rat exposed in utero to doxorubicin","volume":"17","author":"Menegola","year":"2002","journal-title":"Histol Histopathol"},{"key":"10.1093\/annonc\/mdh009_bb0105","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cpt1971126944","article-title":"Clinical pharmacology of 1-\u03b2-d-arabinofuranosyl-cytosine","volume":"12","author":"Ho","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/annonc\/mdh009_bb0110","first-page":"1681","article-title":"Transplacental passage of cyclophosphamide","volume":"66","author":"D\u2019Incalci","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdh009_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-199528030-00005","article-title":"Placental transfer of drugs administered to the mother","volume":"28","author":"Pacifici","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1093\/annonc\/mdh009_bb0120","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1073\/pnas.82.22.7661","article-title":"Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells","volume":"82","author":"Fojo","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdh009_bb0125","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"Smit","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdh009_bb0130","first-page":"595","article-title":"Passage transplacentaire de la doxorubicine","volume":"18","author":"Grohard","year":"1989","journal-title":"J Gynecol Obst Biol Reprod"},{"key":"10.1093\/annonc\/mdh009_bb0135","first-page":"63","article-title":"Passage transplacentaire de l\u2019\u00e9pirubicine","volume":"24","author":"Gaillard","year":"1995","journal-title":"J Gynecol Obstet Bio Reprod"},{"key":"10.1093\/annonc\/mdh009_bb0140","first-page":"1945","article-title":"Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues","volume":"13","author":"Stewart","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdh009_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00000539-200107000-00030","article-title":"The effects of uterine and umbilical blood flows on the transfer of propofol across the human placenta during in vitro perfusion","volume":"93","author":"He","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1093\/annonc\/mdh009_bb0150","first-page":"135","article-title":"Treating breast cancer during pregnancy","volume":"18","author":"Espie","year":"1998","journal-title":"What can be taken safely? Drug Saf"},{"key":"10.1093\/annonc\/mdh009_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10428199509054772","article-title":"Successful chemotherapy including epirubicin on a pregnant non Hodgkin\u2019s lymphoma patient","volume":"20","author":"Goldwasser","year":"1995","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419615243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419615243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/1\/146\/332423\/mdh009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T20:23:48Z","timestamp":1582230228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419615243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0923753419615243"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh009","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}